Blockade of AMPA/kainate receptors can either decrease or increase the survival of cultured neocortical cells depending on the stage of maturation.

Neurotoxicity has often been associated with glutamate receptor stimulation and neuroprotection with glutamate receptor blockade. However, the relationship may be much more complex. We dissociated cells from the rat neocortical anlage at an early stage of prenatal development (embryonic day 14).

Modulation of intracellular calcium in early neural cells by non-NMDA ionotropic glutamate receptors.

Non-NMDA ionotropic receptor channels were longtime thought to be impermeable to calcium. There is now increasing evidence that this is not a general feature. Neural cells bearing non-NMDA receptors permeable to divalent cations can be found not only in the adult CNS, but also at surprisingly early stages of development (well before the onset of synaptogenesis).

Functional AMPA/kainate receptors in human embryonic and foetal central nervous system.

Here, functional AMPA/kainate receptors in human embryonic (5.5-7.5 gestational weeks) and foetal (8-10 gestational weeks) central nervous system tissue, shown by the cobalt labeling method, are reported.

AMPA/kainate receptors modulate the survival in vitro of embryonic brainstem cells.

This study aimed at analyzing the involvement of (RS)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate (AMPA/kainate) receptors in the survival of cultured rat embryonic brainstem cells, dissociated on embryonic day 14. The cell number was estimated after pharmacological manipulation of the receptors by exposure to agonists or antagonists. The developmental stage at the moment of drug application was critical for cell survival.

Functional expression of P-glycoprotein in an immortalised cell line of rat brain endothelial cells, RBE4.

The presence of P-glycoprotein in the cell plasma membrane limits the penetration of many cytotoxic substances into cells that express the gene product. There is considerable evidence also to indicate that P-glycoprotein is expressed as part of the normal blood-brain barrier in the luminal membranes of the cerebral capillary endothelial cells, where it presumably performs a protective function for the brain. This report describes the functional expression of P-glycoprotein in an immortalised cell line, RBE4, derived from rat cerebral capillary endothelial cells.